Andrew Gengos – Biography

Last update: May 18, 2026

Executive profile

Andrew was Chief Financial Officer and Head of Corporate Development at Terns Pharmaceuticals, and Chief Financial Officer at LeonaBio. Andrew Gengos joined Turn Therapeutics in 2026.

Andrew Gengos is currently

Create your alert
to follow the career of Andrew Gengos.

Education

Andrew Gengos has a Bachelor of Science in Chemical Engineering from Massachusetts Institute of Technology in 1986 and a Master of Business Administration in Finance and Strategy from University of California, Los Angeles - Anderson School of Management in 1991.

They have also studied at Massachusetts Institute of Technology :

Find more alumni from Massachusetts Institute of Technology


They have also studied at University of California, Los Angeles - Anderson School of Management :

Find more alumni from University of California, Los Angeles - Anderson School of Management

The colleagues of Andrew Gengos

Company Colleagues
Industry Colleagues
  • In the Healthcare industry, Andrew Gengos has 55,506 colleagues in 3,590 companies located in 59 countries. 39,235 executive movements have been recorded in the last 12 months. Learn more about Healthcare.

Report an error
Update the org chart details of Andrew Gengos.

Get in Touch

Here are a few tips for establishing great contacts.

Share

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.